Philip M. Young - 03 Jun 2026 Form 4 Insider Report for CARLSMED, INC. (CARL)

Reporting relationship: Director
Issuer ticker: CARL
Reported as of: 03 Jun 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 22 Jun 2026, 06:01:41 UTC
Prior SEC filing: 24 Jul 2025
Source filing: View source filing
Reporting owner signature: /s/ Leonard Greenstein, as attorney-in-fact for Philip Young

Key filing fact

Philip M. Young filed Form 4 for CARLSMED, INC. (CARL) on 22 Jun 2026.

Key facts

This page summarizes Philip M. Young's Form 4 filing for CARLSMED, INC. (CARL).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 22 Jun 2026, 06:01.

Change

Previous filing in this sequence was filed on 24 Jul 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001048637 Primary reporting owner

YOUNG PHILIP M

Relationship: Director
Address: C/O CARLSMED, INC., 1800 ASTON AVE., SUITE 100, CARLSBAD
Signature: /s/ Leonard Greenstein, as attorney-in-fact for Philip Young
Signature date: 22 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CARL transaction

Common Stock

Award

Transaction value
Shares: +13,698
Change %: +79%
Price: $0.000000^*
Shares after: 31,031
Date: 03 Jun 2026
Ownership: Direct
Footnotes: F1

CARL holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 35,566
Date: 03 Jun 2026
Ownership: See footnotes
Footnotes: F2, F3

CARL holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 53,333
Date: 03 Jun 2026
Ownership: See footnotes
Footnotes: F4, F5

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

Constitutes an award of restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. The RSUs will vest in full on the earlier of (i) the day before the Issuer's 2027 annual meeting of stockholders or (ii) June 3, 2027, subject, in all cases, to the Reporting Person's continued service as a member of the Board of Directors through such vesting date.

Footnote F2

Stock held by PMY Partners LP.

Footnote F3

Reporting Person is the sole general partner of PMY Partners L.P. and has voting and dispositive power over the stock held by PMY Partners L.P.

Footnote F4

Includes shares of the Issuer's common stock held by the Young Family Trust dtd 04/13/1998 Nancy Halsey Young & Philip Young, Trustees.

Footnote F5

Reporting Person is a trustee of the Trust and has voting and dispositive power over the stock held by the Trust.